Weight Loss Study-Mechanism Underlying the Improvement of Insulin Resistance in Response to Weight Loss

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
ObesityWeight Loss
Interventions
DIETARY_SUPPLEMENT

Weight loss group (Full meal replacement products)

In the intervention arm of this non randomized, open label study to assess the effects of weight loss on insulin sensitivity and leptin tolerance subjects will use full meal replacement products (1280-1320kcal/day). Subjects will be on the full meal replacement products only, for the first 12 weeks, between 13 to 19 weeks they will be transitioned to regular food, from 19 weeks and going forward they will be on chronic maintenance phase

Trial Locations (1)

02115

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
lead

Beth Israel Deaconess Medical Center

OTHER

NCT01780870 - Weight Loss Study-Mechanism Underlying the Improvement of Insulin Resistance in Response to Weight Loss | Biotech Hunter | Biotech Hunter